Cargando…
Triplet CFTR modulators: future prospects for treatment of cystic fibrosis
Cystic fibrosis (CF) is an autosomal recessive genetic disease characterized by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR). CFTR is a chloride channel responsible for ion flow across epithelial surfaces of lung, sinuses, pancreas, intestine, and liver. Researchers ha...
Autor principal: | Chaudary, Nauman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6287538/ https://www.ncbi.nlm.nih.gov/pubmed/30584312 http://dx.doi.org/10.2147/TCRM.S147164 |
Ejemplares similares
-
Airway Clearance Therapy in Cystic Fibrosis Patients Insights from a Clinician Providing Cystic Fibrosis Care
por: Chaudary, Nauman, et al.
Publicado: (2021) -
Cystic Fibrosis and Sleep Circadian Rhythms
por: Louis, Mariam, et al.
Publicado: (2022) -
The Effect of CFTR Modulators on Airway Infection in Cystic Fibrosis
por: Harvey, Caitlyn, et al.
Publicado: (2022) -
CFTR modulators: transformative therapies for cystic fibrosis
por: Dwight, Mary, et al.
Publicado: (2021) -
Cystic Fibrosis, CFTR, and Colorectal Cancer
por: Scott, Patricia, et al.
Publicado: (2020)